SCHEMBL9084352

SCHEMBL9084352

CC(N=C1CCCCN1)(P(=O)(O)O)P(=O)(O)O

nearest known ligand 0.38

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
FKBP5 Q13451 1/20 0.32
CRBN Q96SW2 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8949672 0.70 GABRP (0.34) FKBP5CRBN
SCHEMBL12129960 0.68
SCHEMBL2916419 0.68
SCHEMBL3265053 0.68
SCHEMBL9083443 0.68 FKBP5 (0.34) FKBP5CRBN
SCHEMBL11226687 0.66 TSHR (0.42) FKBP5CRBN
SCHEMBL283680 0.66
SCHEMBL11223666 0.66 TSHR (0.42) FKBP5CRBN
SCHEMBL283682 0.66
SCHEMBL283681 0.66

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5519013-A Heterocycle-substituted diphosphonate compounds, pharmaceutical compositions, and methods of treating abnormal calcium and phosphate metabolism THE PROCTER & GAMBLE COMPANY (US) 1996-05-21 US disclosed
US-5334586-A Heterocycle-substituted diphosphonate compounds, pharmaceutical compositions, and methods of treating abnormal calcium and phosphate metabolism PROCTER & GAMPLE PHARMACEUTICALS, INC. (US) 1994-08-02 US disclosed
EP-0274158-B1 Novel heterocycle-substituted diphosphonate compounds, pharmaceutical compositions, and methods of treating abnormal calcium and phosphate matabolism NORWICH EATON PHARMA (US) 1994-03-23 EP disclosed
US-5071840-A Certain heterocyclic substituted diphosphonate compounds pharmaceutical compositions, and methods of treating abnormal calcium and phosphate metabolism NORWICH EATON PHARMACEUTICALS, INC. (US) 1991-12-10 US disclosed
EP-0351897-A2 Skin penetration system for salts of amine-functional drugs THE PROCTER & GAMBLE COMPANY (US) 1990-01-24 EP disclosed